维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Drilon"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Extraskeletal myxoid chon-drosarcoma:a retrospective review from2referral centers emphasi-zing long-term outcomes with surgery and chemotherapy显示文摘	Drilon AD Popat S Bhuchar G	2008	Cancer2008，113，12：	1
2	Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations inlung adenocarcinomas otherwise negative for such alterations by othergenomic testing approaches 显示文摘	Drilon A Wang L Arcila ME	2015	Clin Cancer Res2015，21，16：	1
3	KIFSB-RET: Dis- covery of a novel fusion oncogene in lung adenocarcinomas by a systematic screen for tyrosine kinase fusions and identification of patients for a RET targeted therapy trial显示文摘	Suehara Y Arcila ME Drilon AEDC	2012	J Clin Oncol2012，30，15：	1
4	Response to cabozantinib in patients with RET fusion-positive lung adenocareinomas显示文摘	Drilon A Wang L Hasanovic A	2013	Cancer Diseov2013，3，6：	1
5	Response to cabozantinib inpatients with RET fusion-positive lung adenocarcinomas 显示文摘	Drilon A Wang L Hasanovic A	2013	CancerDiscov2013，3，6：	1
6	Screening for RET and ROS1 fusions in an enriched co- hort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in tar- geted therapy trials显示文摘	Dela Cruz Drilon AE Wang L Hasanovic A	2013	J Clin Oncol2013，31，15：	1
7	Response to Cabozantinib in patients with RET fusion - positive lung adenocarcinomas 显示文摘	Drilon A Wang L Hasanovic A	2013	Cancer Discov2013，3，6：	1
8	Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine- DNA methyltransferase 显示文摘	Zauderer MG Drilon A Kadota K	2014	Lung Cancer2014，86，2：	1
9	Squamous-cell carcinomas of the lung: emerging biology, controver- sies, and the promise of targeted ther- apy显示文摘	Drilon A Rekhtman N Ladanyi M	2012	Lancet Oncol2012，13，41：	1
10	Extraskeletal myxoid chondrosarcoma:a retrospective review from 2 referral centers emphasizing long term outcomes with surgery and chemotherapy显示文摘	Drilon AD Popat S Bhuchar G		0，，12：	1
11	Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas 显示文摘	Drilon A Wang L Hasanovic A	2013	Cancer discovery2013，3，6：	1
12	Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas显示文摘	Drilon A Wang L Hasanovic A	2013	Cancer Discov2013，3，6：	1
13	KRAS mutations predict sensitivity to Pemetrexed-based chemotherapy显示文摘	Levy B Drilon A1 Chachoua A		0，，04：	1
14	Squamous-cell carcino- mas of the lung:emerging biology, controversies, and the promise of targeted therapy显示文摘	Drilon A Rekhtman N Ladanyi M	2012	Lancet Onco12012，13，10：	1
15	Broad,hybrid capture-based nextgeneration sequencing identifies actionable genomic alterations in 'driver-negative' lung adenocarcinomas显示文摘	Drilon A Wang L Arcila ME	2015	Clin Cancer Res2015，，：	1
16	Squamous-cell carci- nomas of the lung: emerging biology, controversies, and the promise of targeted therapy显示文摘	Drilon A Rekhtman N Ladanyi M	2012	Lancet Oneol2012，13，0：	1
17	Extraskeletal myxoid chondrosarcoma:a retrospective review from 2referral centers emphasizing long-term outcomes with surgery and chemotherapy显示文摘	Drilon AD Popat S Bhuchar G	2008	Cancer2008，113，12：	1
18	Response toCabozantinib in Patients with RET Fusion-Positive Lung Adeno-carcinomas 显示文摘	DRILON A WANG L HASANOVIC A	2013	Cancer2013，3，6：	1
19	Response to MET inhibitors in patients with stage Ⅳ lung adenocarcinomas harboring MET mutations causing exon 14 skipping显示文摘	Paik PK Drilon A Fan PD	2015	Cancer Discov2015，5，8：	1
20	Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping显示文摘	Paik PK Drilon A Fan PD	2015	Cancer Discov2015，5，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示